FDA greenlights first drug for severe frostbite: ‘Very important approval’
[ad_1]
Frostbite may have met its match. The U.S. Food and Drug Administration (FDA) has approved the first medication to treat severe frostbite, the agency announced this week. The drug, iloprost (brand name Aurlumyn) is intended to reduce the risk of finger and toe amputations due to dangerously cold extremities. NEED A 'WINTER RESET'? EXPERTS SHARE BENEFITS OF SLOWING DOWN DURING COLDER MONTHS Iloprost was originally approved for treatment of pulmonary arterial hypertension, a condition in which high blood pressure affects arteries in the lungs and heart . "This approval provides patients with the first-ever treatment option for severe frostbite," said Norman Stockbridge, M.D., Ph.D., director of the Division of Cardiology and Nephrology in the FDA’s Center for Drug Evaluation and Research, in a press release. Frostbite occurs when cold temperatures cause parts of the body to freeze, primarily the fingers, toes, nose, cheeks and chin. (iStock) "Hav